Guided self-help to support emotion regulation in people living with chronic cancer
Tests guided self-help, alone or with group sessions, in adults with metastatic cancer or myeloma.
Plain-language title generated from the registry record
Registry title: e-Motion : Promoting Emotion Regulation in Chronic Cancer
Key facts
- Where
- Brussels, BelgiumSee the 2 sites
Where in Belgium
- H.U.B Institut Jules BordetBrussels, BelgiumTaking people
- Institut Jules Bordet - Hôpital Universitaire de BruxellesBrussels, BelgiumNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Université Libre de Bruxelles
- Trial code
- NCT07236021
- Record updated
- 21 November 2025
- Original description
The present study aimed to pilot evaluate two interventions: a Guided Self-Help Intervention alone, and a combined Group and Guided Self-Help Intervention, designed to support individuals living with chronic cancer and recently diagnosed. The primary aim of this pilot study is to assess the feasibility, acceptability and tolerability of the interventions. The secondary aim of the pilot study is to assess the interventions preliminary efficacy and differences on psychological symptoms.Read full original descriptionShow less
Promoting Emotion Regulation in Patients Living With Chronic Cancer : A Pilot Feasibility, Acceptability and Tolerability Study (e-Motion Project)
The present study aimed to pilot evaluate two interventions: a Guided Self-Help Intervention alone, and a combined Group and Guided Self-Help Intervention, designed to support individuals living with chronic cancer and recently diagnosed. The primary aim of this pilot study is to assess the feasibility, acceptability and tolerability of the interventions. The secondary aim of the pilot study is to assess the interventions preliminary efficacy and differences on psychological symptoms.
Inclusion: Having received a diagnosis of chronic cancer (metastatic breast cancer, metastatic melanoma, metastatic colorectal, metastatic ovarian, metastatic uterine, metastatic endometrial, metastatic prostate, metastatic bladder, metastatic kidney or metastatic testicular cancer, symptomatic multiple myeloma, metastatic non-small cell lung, metastatic mesothelioma or metastatic thymoma) in the past 12 months,; Having completed at least one active treatment session (e.g., chemotherapy, surgery, radiotherapy, immunotherapy, target therapy).
Exclusion: Having more than one treatment line (for triple negative breast cancer, melanoma, gynecological cancer, colorectal cancer, bladder cancer, kidney cancer, non-small cell lung, mesothelioma and thymoma) or two treatment lines (for other breast cancers and testicular cancer) or three treatment lines (for prostate cancer and multiple myeloma),; Having a diagnosis of oligometastatic cancer,; Severe cognitive impairment, and severe and/or acute psychiatric disorder; Age < 18 years,; Having less than one year of life expectancy; Non-fluency in French,; Inability to follow the online intervention,.